Targeting signal transduction as a strategy to treat inflammatory diseases

LAJ O'Neill - Nature reviews Drug discovery, 2006 - nature.com
Inflammatory diseases are a major burden on humanity, despite recent successes with
biopharmaceuticals. Lack of responsiveness and resistance to these drugs, delivery …

New approaches to the treatment of inflammatory disease: focus on small-molecule inhibitors of signal transduction pathways

YA Ivanenkov, KV Balakin, SE Tkachenko - Drugs in R & D, 2008 - Springer
Abstract This 'state-of-the-art'review specifically focuses on alternative signalling pathways
deeply involved in acute and chronic inflammatory responses initiated by various …

Is targeting Toll‐like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine‐driven inflammation?

E Andreakos, B Foxwell, M Feldmann - Immunological reviews, 2004 - Wiley Online Library
Cytokine‐driven inflammation and tissue destruction is a common theme of chronic
inflammatory diseases such as rheumatoid arthritis, Crohn's disease, ulcerative colitis …

New targets for anti-inflammatory drugs

AJ Lewis, AM Manning - Current opinion in chemical biology, 1999 - Elsevier
Inflammatory and autoimmune diseases, including rheumatoid arthritis, inflammatory bowel
diseases, multiple sclerosis, psoriasis and asthma, provide drug discoverers with a …

Targeting innate immunity protein kinase signalling in inflammation

M Gaestel, A Kotlyarov, M Kracht - Nature Reviews Drug Discovery, 2009 - nature.com
Inflammation is an evolutionarily conserved host reaction that is initiated in response to
trauma, tissue damage and infection. It leads to changes in tissue homeostasis and blood …

Signal transduction pathways and transcription factors as therapeutic targets in inflammatory disease: towards innovative antirheumatic therapy

SW Tas, PHJ Remans, KA Reedquist… - Current pharmaceutical …, 2005 - ingentaconnect.com
Many chronic inflammatory diseases are associated with deregulated intracellular signal
transduction pathways. Resultant pathogenic interactions between immune and stromal …

NF-κB signaling and inflammation—Drug repurposing to treat inflammatory disorders?

A Roberti, LE Chaffey, DR Greaves - Biology, 2022 - mdpi.com
Simple Summary Since its first description 35 years ago, the transcription factor NF-κB
(nuclear factor κ-light-chain-enhancer of activated B cells) has been shown to be a key …

Strategies to therapeutically modulate cytokine action

WJ Leonard, JX Lin - Nature Reviews Drug Discovery, 2023 - nature.com
Cytokines are secreted or membrane-presented molecules that mediate broad cellular
functions, including development, differentiation, growth and survival. Accordingly, the …

[PDF][PDF] Pro-inflammatory signaling: last pieces in the NF-κB puzzle?

PA Baeuerle - Current Biology, 1998 - cell.com
Pro-inflammatory signaling: Last pieces in the NF-kB puzzle? Page 1 Dispatch R19 Pro-inflammatory
signaling: Last pieces in the NF-kB puzzle? Patrick A. Baeuerle The discovery of three …

Negative regulatory approaches to the attenuation of Toll-like receptor signaling

MA Anwar, S Basith, S Choi - Experimental & molecular medicine, 2013 - nature.com
Toll-like receptors (TLRs) are pivotal components of the innate immune response, which is
responsible for eradicating invading microorganisms through the induction of inflammatory …